Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Blobel Friedhelm
Relationship:   President, CEO, Direct...
City:   San Mateo
State:   CA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   0    

Indirect Shares

  0      
Direct Value   $0    

Indirect Value

  $0      
Total Shares   0      
Total Value   $0      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Sciclone Pharmaceuticals Inc SCLN President, CEO, Direct... 2017-10-13 0 2007-11-20 0    Premium*  
* Premium Members only  

Records found :    173         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2016-08-17 4 S $10.00 $5,018,750 D/D (501,875) 86,380 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2016-10-27 4 AS $9.30 $371,892 D/D (40,000) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2016-11-11 4 AS $10.01 $53,051 D/D (5,301) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2016-11-14 4 AS $10.33 $255,086 D/D (24,699) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2016-11-21 4 AS $10.22 $570,913 D/D (55,853) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2016-11-22 4 AS $10.20 $144,265 D/D (14,147) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2016-12-21 4 AS $10.54 $666,619 D/D (63,099) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2016-12-22 4 AS $10.40 $71,748 D/D (6,901) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-03 4 AS $11.00 $3,300 D/D (300) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-04 4 AS $11.00 $1,100 D/D (100) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-05 4 AS $11.02 $101,388 D/D (9,200) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-20 4 AS $10.38 $128,741 D/D (12,400) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-23 4 AS $10.41 $237,508 D/D (22,807) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-24 4 AS $10.41 $271,986 D/D (25,925) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-25 4 AS $10.54 $93,439 D/D (8,868) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-21 4 AS $9.86 $198,956 D/D (20,176) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-22 4 AS $9.86 $90,714 D/D (9,201) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-23 4 AS $9.76 $95,609 D/D (9,800) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-24 4 AS $9.71 $7,993 D/D (823) 86,784 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-04 4 OE $1.81 $181 D/D 100 86,884 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-03 4 OE $1.81 $543 D/D 300 87,084 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-01 4 AS $10.00 $92,010 D/D (9,200) 87,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-02 4 AS $10.01 $44,198 D/D (4,417) 87,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-03 4 AS $10.03 $133,315 D/D (13,296) 87,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-06 4 AS $10.30 $31,787 D/D (3,087) 87,526 0 -

  173  Records found
  1   2  3   4   5   6   7      
  Page 2 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed